LTR Pharma Limited (ASX: LTP)

LTR Pharma Statistics

Total Valuation

LTR Pharma has a market cap or net worth of AUD 188.41 million. The enterprise value is 185.31 million.

Market Cap	188.41M
Enterprise Value	185.31M

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

LTR Pharma has 153.80 million shares outstanding. The number of shares has decreased by -46.36% in one year.

Current Share Class	n/a
Shares Outstanding	153.80M
Shares Change (YoY)	-46.36%
Shares Change (QoQ)	-0.10%
Owned by Insiders (%)	7.88%
Owned by Institutions (%)	1.02%
Float	74.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	58.08
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-26.65
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-36.37

Financial Position

The company has a current ratio of 7.86

Current Ratio	7.86
Quick Ratio	7.86
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16,445.02

Financial Efficiency

Return on equity (ROE) is -277.45% and return on invested capital (ROIC) is -173.04%.

Return on Equity (ROE)	-277.45%
Return on Assets (ROA)	-158.79%
Return on Capital (ROIC)	-173.04%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	1.57
200-Day Moving Average	0.88
Relative Strength Index (RSI)	39.07
Average Volume (20 Days)	105,444

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LTR Pharma had revenue of AUD 49,002 and -6.95 million in losses. Loss per share was -0.05.

Revenue	49,002
Gross Profit	49,002
Operating Income	-6.94M
Pretax Income	-6.95M
Net Income	-6.95M
EBITDA	n/a
EBIT	-6.94M
Loss Per Share	-0.05

Balance Sheet

Cash & Cash Equivalents	3.10M
Total Debt	n/a
Net Cash	3.10M
Net Cash Per Share	0.02
Equity (Book Value)	2.94M
Book Value Per Share	0.02
Working Capital	2.94M

Cash Flow

In the last 12 months, operating cash flow was -5.09 million and capital expenditures -1,976, giving a free cash flow of -5.09 million.

Operating Cash Flow	-5.09M
Capital Expenditures	-1,976
Free Cash Flow	-5.09M
FCF Per Share	-0.03

Margins

Gross Margin	100.00%
Operating Margin	-14,162.28%
Pretax Margin	-14,192.25%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-10,396.58%

Dividends & Yields

LTR Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	46.36%
Shareholder Yield	46.36%
Earnings Yield	-4.07%
FCF Yield	-2.70%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LTR Pharma has an Altman Z-Score of 63.35.

Altman Z-Score	63.35
Piotroski F-Score	n/a